08.03.2023 | Journal Club
Optimaler Behandlungsweg bei diabetischer Polyneuropathie
Erschienen in: Schmerz Nachrichten | Ausgabe 1/2023
Einloggen, um Zugang zu erhaltenAuszug
Tesfaye S, Sloan G, Selvarajah D, et al, on behalf of the OPTION-DM trial group (2022) Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. Lancet; 400:680–90. …Anzeige